Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence

Shelley N. Facente, Angela M. Reiersen, Eric J. Lenze, David R. Boulware, Jeffrey D. Klausner

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence'. Together they form a unique fingerprint.

Medicine & Life Sciences